Thomas McDonald, MD

Care Provider Overall: 
5
Provider Reviews: 
71
  • Clinical Details
  • Education
  • News & Video
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Corning Hospital
  • Guthrie Robert Packer Hospital
  • Guthrie Troy Community Hospital
Clinical Interests: 
  • Hepatobiliary Cancer

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of Recommending Care Provider: 
5
Patients' Confidence in Care Provider: 
5
Time Care Provider Spent with Patient: 
5
Care Provider Spoke Using Clear Language: 
5
Care Provider Efforts to Include in Decisions: 
5
Care Provider's Concern for Questions and Worries: 
5
Care Provider's Explanations of Condition/Problem: 
5
Care Provider Information About Medications: 
5
Care Provider Instructions for Follow-Up Care: 
5
Care Provider's Friendliness and Courtesy: 
5
Residency: 
  • Robert Packer Hospital, Sayre, Pa.
Certification: 
  • American Board of Internal Medicine
Education: 
  • Hahnemann University, Philadelphia, Pa.
Internship: 
  • Robert Packer Hospital, Sayre, Pa.
Fellowship: 
  • Robert Packer Hospital, Sayre, Pa.
  • University of Miami, Miami, Fla.
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: McDonald M.D., Thomas
Sponsor: Janssen
Details (Identifier #): none
Title: Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophageal reflux disease and other gastrointestinal motility disorders. CIS-USA-154
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: McDonald M.D., Thomas
Sponsor: Eli Lilly
Details (Identifier #): NCT02891226
Title: 16T-MC-AMAG, A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Liver
Principal Investigator: McDonald M.D., Thomas
Sponsor: Gilead Sciences
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Liver
Principal Investigator: McDonald M.D., Thomas
Sponsor: Gilead Sciences
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Guthrie Patient: June 2017
doctor very concerned since what he went in to fix wound up more serious.
Guthrie Patient: May 2017
I specifically asked for him and was very willing to wait another week.
Guthrie Patient: May 2017
Not one thing that was not the best!
Guthrie Patient: May 2017
*Dr. McDonald never stopped by post-procedure & explain results to my wife & myself.
Guthrie Patient: December 2016
Dr. McDonald is outstanding. I do not know how he balances procedures and office time. Please provide support for his continued excellence and get additional staffing.